Companies House does not verify the accuracy of the information filed

Advanced company search

HANSA BIOPHARMA LIMITED

Company number 08361712

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Company Results (links open in a new window)
Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
31 Jul 2015	RP04	Second filing of SH01 previously delivered to Companies House ANNOTATION Clarification Second filing SH01 for 18/02/2013	View PDF Second filing of SH01 previously delivered to Companies House ANNOTATION Clarification Second filing SH01 for 18/02/2013 - link opens in a new window - 6 pages (6 pages)
30 Jan 2015	AR01	Annual return made up to 15 January 2015 with full list of shareholders Statement of capital on 2015-01-30 GBP 9 Statement of capital on 2015-08-18 GBP 10 ANNOTATION Clarification a Second filed AR01 is registered on 18/08/2015	View PDF Annual return made up to 15 January 2015 with full list of shareholders Statement of capital on 2015-01-30 GBP 9 Statement of capital on 2015-08-18 GBP 10 ANNOTATION Clarification a Second filed AR01 is registered on 18/08/2015 - link opens in a new window - 6 pages (6 pages)
16 May 2014	AA	Total exemption small company accounts made up to 31 January 2014	View PDF Total exemption small company accounts made up to 31 January 2014 - link opens in a new window - 5 pages (5 pages)
14 Mar 2014	SH01	Statement of capital following an allotment of shares on 18 February 2013 GBP 9 ANNOTATION Clarification a second filed SH01 was registered on 31/07/2015	View PDF Statement of capital following an allotment of shares on 18 February 2013 GBP 9 ANNOTATION Clarification a second filed SH01 was registered on 31/07/2015 - link opens in a new window - 4 pages (4 pages)
11 Mar 2014	AP01	Appointment of Mr Charles Denis Scanlan as a director	View PDF Appointment of Mr Charles Denis Scanlan as a director - link opens in a new window - 2 pages (2 pages)
15 Jan 2014	AR01	Annual return made up to 15 January 2014 with full list of shareholders Statement of capital on 2014-01-15 GBP 9 ANNOTATION Clarification a Second filed AR01 is registered on 18/08/2015	View PDF Annual return made up to 15 January 2014 with full list of shareholders Statement of capital on 2014-01-15 GBP 9 ANNOTATION Clarification a Second filed AR01 is registered on 18/08/2015 - link opens in a new window - 5 pages (5 pages)
09 Oct 2013	CERTNM	Company name changed oxford antibodies LIMITED\certificate issued on 09/10/13 RES15 ‐ Change company name resolution on 2013-10-06 NM01 ‐ Change of name by resolution	View PDF Company name changed oxford antibodies LIMITED\certificate issued on 09/10/13 RES15 ‐ Change company name resolution on 2013-10-06 NM01 ‐ Change of name by resolution - link opens in a new window - 3 pages (3 pages)
21 Aug 2013	TM01	Termination of appointment of Peter Laing as a director	View PDF Termination of appointment of Peter Laing as a director - link opens in a new window - 1 page (1 page)
08 May 2013	TM01	Termination of appointment of Christopher Scanlan as a director	View PDF Termination of appointment of Christopher Scanlan as a director - link opens in a new window - 1 page (1 page)
16 Feb 2013	AP01	Appointment of Dr Peter Laing as a director	View PDF Appointment of Dr Peter Laing as a director - link opens in a new window - 2 pages (2 pages)
16 Feb 2013	SH01	Statement of capital following an allotment of shares on 15 February 2013 GBP 10	View PDF Statement of capital following an allotment of shares on 15 February 2013 GBP 10 - link opens in a new window - 3 pages (3 pages)
15 Jan 2013	NEWINC	Incorporation MODEL ARTICLES ‐ Model articles adopted	View PDF Incorporation MODEL ARTICLES ‐ Model articles adopted - link opens in a new window - 9 pages (9 pages)

Tell us what you think of this service Is there anything wrong with this page?